From Editor's desk

Agrawal, Ranjan

doi:10.4103/0377-4929.351627

Cited by 1 publication

(2 citation statements)

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Imaging was unremarkable in the abdomen, but chest CT was indicative of lung ground-glass opacities suggestive of COVID-19. In 2022, Agarwal et al reported the case of a COVID-19 patient who presented with acute pancreatitis, under the hypothesis that pancreatic injury is the result of SARS-CoV-2 virus entry via angiotensinconverting enzyme 2 (ACE2) receptor [1]. Early in the pandemic, a patient with a history of autoimmune hepatitis (AIH) and recent travel presented primarily with symptoms of liver failure including jaundice, ascites, and transaminitis [25].…”

Section: Discussionmentioning

confidence: 99%

“…The coronavirus disease 2019 (COVID-19) infection primarily results in respiratory symptoms and manifestations such as cough, shortness of breath, phlegm, congestion, and rhinorrhea [1]. However, gastrointestinal (GI) symptoms have been reported to occur in approximately 17% of patients [1]. The most common symptoms reported are anorexia, nausea, diarrhea, abdominal pain, and vomiting [2,3].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

COVID-19 and Its Sequelae Masquerading as Gastrointestinal Ailments: A Report of Gastroesophageal Reflux Disease (GERD) and Review of Recent Cases

Shweikeh,

Hong,

Rabeeah

et al. 2024

Cureus

View full text Add to dashboard Cite

Coronavirus disease 2019 (COVID-19) predominantly causes respiratory symptoms. However, a rare segment of patients recovering from COVID-19 may develop gastrointestinal (GI) symptoms. We describe a case of a female who presented with symptoms suggestive of refractory gastroesophageal reflux disease (GERD) for 18 months following COVID-19 infection. Her symptoms included epigastric and chest pain, coughing, and vomiting. Upper endoscopy and 24-hour pH monitoring were negative. Following hospital admission due to worsening symptoms, she was diagnosed with chronic pulmonary embolism (PE) presumed to be related to COVID-19. Her reflux symptoms resolved within two days of the initiation of anticoagulation. Our findings suggest that chronic PE should be considered in patients presenting with GERD refractory to treatment following COVID-19 infection. Generally, as COVID-19 and its sequelae may masquerade as GI conditions, they should be on the differential diagnosis, especially in the post-pandemic era when routine testing has significantly declined.

show abstract

Section: Discussionmentioning

confidence: 99%